Myrica cerifera
Myrica cerifera · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Myrica cerifera is a botanical species of significant interest due to the diverse therapeutic potential found within its root. Scientific investigations into its ethanolic, methylene chloride, and methanol extracts have revealed a rich profile of bioactive chemicals, including myricitrin and myriceric acids A, C, and D. These compounds exhibit a wide range of pharmacological activities, such as antibacterial properties against Staphylococcus aureus and inhibition of 5-alpha-reductase, ACE, and AChE. Furthermore, research involving Caenorhabditis elegans suggests these extracts may offer protective benefits against cardiovascular diseases and the coronavirus. Consequently, this plant serves as a promising subject for developing new treatments through its specialized chemical constituents.
- Synonyms
- Morella Domingana · Pimecaria Odorata · 24 more
- Common names
- Not available
- Family
- Myricaceae
- Distribution
- Asia-Temperate
- Plant Parts
- Root
Classification
Synonyms
Myrica cerifera is a plant species that has been classified under several different botanical names throughout history. It is recognized by various synonyms, including the designations Cerophora angustifolia and Cerophora inodora. The plant's complex taxonomic record also encompasses the names Cerophora lanceolata and Cerophora spicans. Additionally, it has been referred to in scientific literature as Cerothamnus cerifer. Understanding these diverse nomenclatural relationships is essential for accurate identification in botanical studies.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Myrica cerifera belongs to the kingdom Plantae, a vast group encompassing all known land plants. Within this realm, it is classified under the class Equisetopsida and the order Fagales. The plant is a member of the Myricaceae family, which showcases its distinct botanical characteristics. It is further identified by its specific genus, Myrica, which helps scientists categorize its unique evolutionary traits. Understanding these taxonomic relationships provides essential insight into the biological identity of this species.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fagales |
| Family | Myricaceae |
| Genus | Myrica |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Myrica cerifera exhibits a broad and diverse geographical range that spans across much of North America. Within Mexico, the species is remarkably widespread, establishing itself in a variety of distinct regional environments. It can be found throughout the central territories and along the expansive Gulf coasts. Furthermore, its presence extends into the northeast and southeast regions of the country. The plant's adaptability is further evidenced by its successful distribution throughout the Mexican southwest.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Myrica cerifera is a self-supporting plant that takes on a distinct tree-like growth form. This species is capable of reaching a maximum height of approximately 8.4 meters. Its sturdy structure allows it to stand independently as it matures within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Myrica cerifera, commonly known as wax myrtle, demonstrates significant biological potential through its diverse medicinal properties. Research indicates that extracts from this plant possess notable antibacterial activity, specifically showing effectiveness against strains such as Staphylococcus epidermidis and Staphylococcus aureus. Beyond fighting infection, the plant also exhibits antiproliferative potential when tested against human cancer cell lines like HepG2 and HeLa. These results suggest that the bioactive compounds found within the plant can inhibit cell growth in a dose- and time-dependent manner. Ultimately, the utilization of Myrica cerifera extracts could play a vital role in the development of novel antibacterial and chemotherapeutic drugs.
Compounds
Myrica cerifera, commonly known as the bayberry, serves as a rich source of several bioactive phytochemicals with significant therapeutic potential. Among its most notable constituents is the natural flavonoid myricitrin, which has demonstrated strong antioxidative properties and the ability to protect against endothelial damage and atherosclerosis. The plant also yields important triterpenoids, including myriceric acid A, which functions as a non-peptide endothelin receptor antagonist. Additionally, related compounds such as myriceric acid C and myriceric acid D have been isolated from its structure. Together, these diverse chemical components highlight the medicinal importance of the species in addressing cardiovascular and viral challenges.
Conditions
Myrica cerifera demonstrates significant therapeutic potential by reducing the lifespan of the nematode Caenorhabditis elegans. The plant's isolated flavonoid, myricitrin, effectively treats H2O2-induced apoptosis in vascular endothelial cells (VECs). Furthermore, Myrica cerifera acts to mitigate H2O2-induced endothelial injury within primary cultured human VECs. This protective effect extends to in vivo studies, where it treats H2O2-induced rat models of artery endothelial injury. Finally, ethanolic extracts of Myrica cerifera exhibit antiproliferative activity that helps treat HeLa human cancer cells.
Preparations
Myrica cerifera is prepared as ethanolic extracts to test for antiproliferative potential against HepG2 and HeLa human cancer cell lines. This plant is also processed as a general extract to evaluate its antibacterial and nematicidal properties against organisms like Staphylococcus and C. elegans. Furthermore, Myrica cerifera is prepared as methylene chloride and methanol extracts to determine its antithrombin activity. These various preparation methods allow researchers to isolate bioactive compounds for medicinal applications. Through these different extraction processes, the plant's therapeutic potential in combating cancer, bacteria, and parasites is effectively studied.
Parts used
Myrica cerifera provides a valuable source of bioactive compounds found within its root bark. Specifically, researchers have isolated a natural flavonoid known as myricitrin from this plant part. This potent substance has demonstrated significant antioxidative effects that can protect against vascular endothelial cell damage. In studies involving atherosclerosis models, myricitrin was shown to inhibit early plaque formation and prevent cellular apoptosis. Consequently, this plant component holds great promise for future cardiovascular disease treatments.